Metraipolis › archive › dc_bfb48d61e83f

Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density… — Europe PMC PMID:41601579

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41601579
DOI
10.7717/peerj.20668
License (as archived)
solo-consultazione
Archived
2026-11-06T13:16:03.633Z
SHA-256 of the archived text
d6edba5e527e2b1abebcea297bf583bed91aa927ac68e56c27a06d4b5f0c3d73
Stable URL of this page
https://metraipolis.com/documento/dc_bfb48d61e83f

How to cite

Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density… — Europe PMC PMID:41601579 — Europe PMC (en), https://europepmc.org/article/MED/41601579 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfb48d61e83f (Metraipolis archive dc_bfb48d61e83f, sha256 d6edba5e527e2b1abebcea297bf583bed91aa927ac68e56c27a06d4b5f0c3d73)
BibTeX
@misc{dcbfb48d61e83f,
  title = {Impact of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on intracranial atherosclerotic plaque characteristics and low density… — Europe PMC PMID:41601579},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41601579},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfb48d61e83f; sha256 d6edba5e527e2b1abebcea297bf583bed91aa927ac68e56c27a06d4b5f0c3d73},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601579. Agents can read the archived copy with the MCP tool read_document.